Abstract:A typographical error appeared in the author affiliation titled “Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells”, published in Anti-Cancer Agents in Medicinal Chemistry, 2023, 23(15) [1]. Details of the error and a correction are provided here. Original: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital Chinese Academy of Medical Science, Liaoning Provincial Cancer Hospital, Shenyang, Liaoning, 110042, China Corrected: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, China We regret the error and apologize to readers. The original article can be found online at https://www.eurekaselect.com/article/131718

Corrigendum To: Application of Two New Feature Fusion Networks to Improve Realtime Prostate Capsula Detection.

Corrigendum: Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis.

Erratum To: Application and Prospect of Mixed Reality Technology in Medical Field

Corrigendum to "AFEX-Net: Adaptive feature extraction convolutional neural network for classifying computerized tomography images"

Corrigendum: Radiomic Machine Learning and External Validation Based on 3.0T Mpmri for Prediction of Intraductal Carcinoma of Prostate with Different Proportion

Correction: Jin Et Al. Interobserver Agreement in Automatic Segmentation Annotation of Prostate Magnetic Resonance Imaging. Bioengineering 2023, 10, 1340

Correction: Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study

Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529]

Corrigendum to: Progress of Angiogenesis Signal Pathway and Antiangiogenic Drugs in Nasopharyngeal Carcinoma

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Corrigendum to “system Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma”

Correction To: Marker Ki-67 is a Potential Biomarker for the Diagnosis and Prognosis of Prostate Cancer Based on Two Cohorts

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Corrigendum to “1D CNN-Based Intracranial Aneurysms Detection in 3D TOF-MRA”

Corrigendum: Comparison of the proliferation and differentiation potential of human urine-, placenta decidua basalis-, and bone marrow-derived stem cells (Stem Cells International (2018) 2018 (7131532) DOI: 10.1155/2018/7131532)

Corrigendum: Detection algorithm for pigmented skin disease based on classifier-level and feature-level fusion

Corrigendum to “Treatment-Related Adverse Events Associated with HER2-Targeted Antibody-Drug Conjugates in Clinical Trials: a Systematic Review and Meta-Analysis” [eclinicalmedicine 55 (2022) 101795]

Corrigendum: A comparative study of two in vivo PET verification methods in clinical cases

Corrigendum: Microfluidic-based human prostate-cancer-on-chip

[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer

Prostate Specific Membrane Antigen (PSMA): A Novel Modulator of P38 for Proliferation, Migration, and Survival in Prostate Cancer Cells